Dr. Timothy Chase, a urogynecologist with Novant Health Glen Meade OB/GYN talks with Jessica Keisling about bladder issues.

Catheter Precision, Inc. (NYSE American:VTAK), currently valued at $3.55 million in market capitalization, recently held a ...

Changer for Caregivers and Patients Alike - Uncover Opportunities for Manufacturers Urinary Bag Market Urinary Bag Market ...

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...

At least half of women experience urinary incontinence at some point in their lives but few discuss the condition with their physicians. In part, that’s because most women believe few effective ...

Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.

The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...

UB researcher Chelsie Armbruster is looking at how the urinary tract defends against infection and how understudied pathogens ...